US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Peregrine Pharmaceuticals Inc. (MM) (PPHMD)
Peregrine Pharmaceuticals Inc. (MM) (PPHMD) ニュース

PPHMD

Peregrine Pharmaceuticals Inc. (MM) (PPHMD)

Peregrine Pharmaceuticals Inc. (MM)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PPHMD

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2019/03/30	07 : 42	Business Wire	Announcing VanEck Vectors ETFs’ March 2019 Distributions	NASDAQ:PPHMD	Peregrine Pharmaceuticals Inc. (MM)
2018/12/27	08 : 37	Business Wire	Announcing VanEck Vectors Equity ETFs December 2018 Distribution	NASDAQ:PPHMD	Peregrine Pharmaceuticals Inc. (MM)
2018/10/18	00 : 48	Business Wire	VanEck Launches ESPO, ETF Focused on Fast Growing Video Game and eSports Industry	NASDAQ:PPHMD	Peregrine Pharmaceuticals Inc. (MM)
2018/09/29	07 : 03	Business Wire	Announcing VanEck Vectors Equity ETFs’ September 2018 Distributions	NASDAQ:PPHMD	Peregrine Pharmaceuticals Inc. (MM)
2018/06/30	07 : 15	Business Wire	Announcing VanEck Vectors Equity ETFs June 2018 Distributions	NASDAQ:PPHMD	Peregrine Pharmaceuticals Inc. (MM)
2018/03/30	06 : 58	Business Wire	Announcing VanEck Vectors Equity ETFs March 2018 Distributions	NASDAQ:PPHMD	Peregrine Pharmaceuticals Inc. (MM)
2009/11/10	23 : 30	PR Newswire (US)	New Study in Clinical Cancer Research Shows Therapeutic Promise of Peregrine's Bavituximab With Radiation in a Lethal Brain Canc	NASDAQ:PPHMD	Peregrine Pharmaceuticals Inc. (MM)
2009/11/05	04 : 17	PR Newswire (US)	Peregrine Pharmaceuticals Awarded Second Broad U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies	NASDAQ:PPHMD	Peregrine Pharmaceuticals Inc. (MM)
2009/11/04	05 : 00	PR Newswire (US)	Peregrine Pharmaceuticals Regains Full Compliance With Nasdaq Continued Listing Requirements	NASDAQ:PPHMD
2009/10/27	21 : 17	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:PPHMD	Peregrine Pharmaceuticals Inc. (MM)
2009/10/24	06 : 34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PPHMD	Peregrine Pharmaceuticals Inc. (MM)
2009/10/21	22 : 30	PR Newswire (US)	Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer	NASDAQ:PPHMD
2009/10/19	22 : 30	PR Newswire (US)	Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs	NASDAQ:PPHMD
2009/10/19	21 : 30	PR Newswire (US)	Peregrine Pharmaceuticals 1:5 Reverse Stock Split Takes Effect	NASDAQ:PPHMD
2009/10/19	20 : 44	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:PPHMD	Peregrine Pharmaceuticals Inc. (MM)

Showing the most relevant articles for your search:NASDAQ:PPHMD

1

NLBNPIT1Y8K5 20351221 4....

Money Forward (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約